Thimble Point Acquisition Corp - Ordinary Shares - Class A

NASDAQ:THMA  
9.45
+0.32 (+3.52%)
Other Pre-Announcement

Pear Therapeutics Reaffirms Full Year 2021 Revenue Guidance

Published: 11/15/2021 14:18 GMT
Thimble Point Acquisition Corp - Ordinary Shares - Class A (THMA) - Pear Therapeutics Provides 2021 Business Update and Reaffirms Full Year 2021 Revenue Guidance.
Pear Therapeutics - Reaffirms Its $4 Million Revenue Guidance for Full Year 2021.